Deferiprone

Back to search

Molecule Structure

Scientific Name

Deferiprone

Description of the Drug

Deferiprone is an iron chelator used to treat patients with transfusional iron overload caused by thalassemia syndromes.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08826

Brand Name(s)

Ferriprox

Company Owner(s)

Chiesi Usa Inc, Hikma Pharmaceuticals Usa Inc, Taro Pharmaceutical Industries Ltd

Mechanism(s) Of Action

Not Available

Unichem Links

SureChEMBL SCHEMBL94474
PharmGKB PA166118041
Human Metabolome Database HMDB0250932
DrugBank DB08826
PubChem: Thomson Pharma 15120034
PubChem 2972
Mcule MCULE-6406005067
NMRShiftDB 20208688
LINCS LSM-36972
Nikkaji J134.056E
BindingDB 50525976
EPA CompTox Dashboard DTXSID6040666
DrugCentral 4188
Brenda 102002 223261 5318
ChemicalBook CB0308124
Guide to Pharmacology 7456
rxnorm DEFERIPRONE FERRIPROX
PubChem: Drugs of the Future 12014095
ChEBI 68554
ZINC ZINC000000006226